iRhythm names new CEO, company’s fourth in less than a year
iRhythm Technologies, a San Francisco-based digital health company focused on the treatment of cardiac arrhythmias, has named Quentin Blackford its new president and CEO. The move is effective Oct. 4.
iRhythm’s leadership team has gone through multiple changes in the last year. Kevin King retired as president and CEO in December 2020, a change that was went into effect on Jan. 12, 2021. He was replaced by Mike Coyle, who had years of prior experience with Medtronic, but Coyle resigned from the position in June. Douglas Devine has been serving as the company’s interim CEO.
Blackford has more than 20 years of leadership experience in the medical device industry. He most recently served as the chief operating officer of Dexcom Inc.
“I am excited to be joining iRhythm as CEO,” he said. “iRhythm’s business is built around innovative technology with differentiated capabilities that providers and patients value. This is a powerful platform for growth, and I am looking forward to joining the iRhythm team to help capitalize on the company’s many opportunities."
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.